None listed
Conditions
Brief summary
Expanded access use of INCB052793 to treat a single patient with Myelofibrosis.
Interventions
DRUGINCB052793
Sponsors
Incyte Corporation
Eligibility
Inclusion criteria
\-
Exclusion criteria
\-
Outcome results
None listed